Skip to main content
Equibles

PAIYY · Aesthetic Medical International Holdings Group Ltd

Track PAIYY — free

Use PAIYY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.02 At close · Aug 25
Rebalance outlook locked
Market Cap
$827,689
Shares
48.69M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
722.86M -4.3%
FY2025 Revenue FY2017–FY2025
Net Income
-53.35M -167.5%
FY2025 Net Income FY2017–FY2025
Gross Margin
46.24% +1.5pp
FY2025 Gross Margin FY2017–FY2025
Operating Cash Flow
-12.23M -115.3%
FY2025 Operating Cash Flow FY2017–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
CNY 722.86M 755.67M 682.59M 670.09M 645.59M 901.57M 869.05M 761.31M 697.4M
CNY 388.61M 417.89M 360.54M 314.51M 376.09M 356.8M 275.95M 258.57M 234.52M
CNY 334.25M 337.79M 322.05M 355.59M 269.5M 544.78M 593.1M 502.74M 462.87M
CNY 102.65M 100.79M 138.61M 150.38M 206.97M 230.65M 196.33M 115.49M 92.84M
CNY 58.89M 65.96M 65.9M 61.49M 99.14M 106.41M 83.83M 32.14M 29.11M
CNY 8.75M 8.72M 14.47M 21.64M 27.23M 29.19M 24.29M 9.24M 6.58M
CNY -24.72M -1.35M -55.06M -94.17M -681.31M -259.49M 152.36M -233.97M -53.17M
CNY 29.35M 23.73M -15.14M -18.07M -11.8M -12.59M 14.04M 18.51M 19.26M
CNY -53.35M -19.95M -37.43M -76.25M -586.62M -235.48M 136.31M -255.24M -76.68M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2025: $6.03M in buybacks.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.

Key facts CIK 1757143 Visit website Investor relations